{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:38:14Z","timestamp":1792550294380,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK119254"],"award-info":[{"award-number":["R01DK119254"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK116074"],"award-info":[{"award-number":["P30DK116074"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000963","name":"American Diabetes Association Research Foundation","doi-asserted-by":"publisher","award":["1-18-JDF-011"],"award-info":[{"award-number":["1-18-JDF-011"]}],"id":[{"id":"10.13039\/100000963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s11095-022-03367-y","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T16:02:35Z","timestamp":1660752155000},"page":"2721-2728","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Formulation Excipients and Their Role in Insulin Stability and Association State in Formulation"],"prefix":"10.1007","volume":"39","author":[{"given":"Caitlin L.","family":"Maikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslee T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"3367_CR1","unstructured":"International Diabetes Federation IDF Diabetes Atlas, 9th edn.. 2019. https:\/\/www.diabetesatlas.org."},{"key":"3367_CR2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1177\/193229681200600409","volume":"6","author":"E Cengiz","year":"2012","unstructured":"Cengiz E. Undeniable need for ultrafast-acting insulin: the pediatric perspective. J Diabetes Sci Technol. 2012;6:797\u2013801.","journal-title":"J Diabetes Sci Technol"},{"key":"3367_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/dom.13052","volume":"20","author":"V Gingras","year":"2018","unstructured":"Gingras V, Taleb N, Roy-Fleming A, Legault L, Rabasa-Lhoret R. The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes. Diabetes Obes Metab. 2018;20:245\u201356.","journal-title":"Diabetes Obes Metab"},{"key":"3367_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1172\/JCI113339","volume":"81","author":"KS Polonsky","year":"1988","unstructured":"Polonsky KS, Given BD, Van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest. 1988;81:442\u20138.","journal-title":"J Clin Invest"},{"key":"3367_CR5","first-page":"E349","volume":"254","author":"H Tillil","year":"1988","unstructured":"Tillil H, Shapiro ET, Miller MA, Karrison T, Frank BH, Galloway JA, Rubenstein AH, Polonsky KS. Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans. Am J Physiol. 1988;254:E349\u201357.","journal-title":"Am J Physiol"},{"key":"3367_CR6","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.2337\/diabetes.54.4.1100","volume":"54","author":"RA Heptulla","year":"2005","unstructured":"Heptulla RA, Rodriguez LM, Bomgaars L, Haymond MW. The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes. Diabetes. 2005;54:1100.","journal-title":"Diabetes"},{"key":"3367_CR7","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.2337\/db11-1478","volume":"61","author":"A Saad","year":"2012","unstructured":"Saad A, Dalla Man C, Nandy DK, Levine JA, Bharucha AE, Rizza RA, Basu R, Carter RE, Cobelli C, Kudva YC, Basu A. Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes. 2012;61:2691.","journal-title":"Diabetes"},{"key":"3367_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/dom.12803","volume":"19","author":"T Heise","year":"2017","unstructured":"Heise T, Zijlstra E, Nosek L, Rikte T, Haahr H. Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial. Diabetes Obes Metab. 2017;19:208\u201315.","journal-title":"Diabetes Obes Metab"},{"key":"3367_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jcjd.2019.01.004","volume":"43","author":"P Senior","year":"2019","unstructured":"Senior P, Hramiak I. Fast-acting insulin aspart and the need for new mealtime insulin analogues in adults with type 1 and type 2 diabetes: a Canadian perspective. Can J Diabetes. 2019;43:515\u201323.","journal-title":"Can J Diabetes"},{"key":"3367_CR10","doi-asserted-by":"publisher","first-page":"21449","DOI":"10.1074\/jbc.M314141200","volume":"279","author":"QX Hua","year":"2004","unstructured":"Hua QX, Weiss MA. Mechanism of insulin fibrillation: the structure of insulin under amyloidogenic conditions resembles a protein-folding intermediate. J Biol Chem. 2004;279:21449\u201360.","journal-title":"J Biol Chem"},{"key":"3367_CR11","doi-asserted-by":"crossref","unstructured":"Woods RJ, Alarcon J, McVey E, Pettis RJ. Intrinsic fibrillation of fast-acting insulin analogs. J Diabetes Sci Technol. 2012;6:265\u201376.","DOI":"10.1177\/193229681200600209"},{"key":"3367_CR12","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.addr.2011.07.006","volume":"63","author":"TJ Kamerzell","year":"2011","unstructured":"Kamerzell TJ, Esfandiary R, Joshi SB, Middaugh CR, Volkin DB. Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development. Adv Drug Deliv Rev. 2011;63:1118\u201359.","journal-title":"Adv Drug Deliv Rev"},{"key":"3367_CR13","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1080\/03639045.2018.1483392","volume":"44","author":"BM Rayaprolu","year":"2018","unstructured":"Rayaprolu BM, Strawser JJ, Anyarambhatla G. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics. Drug Dev Ind Pharm. 2018;44:1565\u201371.","journal-title":"Drug Dev Ind Pharm"},{"key":"3367_CR14","doi-asserted-by":"crossref","unstructured":"Xu Y, Yan Y, Seeman D, Sun L, Dubin PL. Multimerization and aggregation of native-state insulin: effect of zinc. Langmuir. 2012;28:579\u201386","DOI":"10.1021\/la202902a"},{"key":"3367_CR15","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1007\/s11095-017-2233-0","volume":"34","author":"K Gast","year":"2017","unstructured":"Gast K, Sch\u00fcler A, Wolff M, Thalhammer A, Berchtold H, Nagel N, Lenherr G, Hauck G, Seckler R. Rapid-acting and human insulins: hexamer dissociation kinetics upon dilution of the pharmaceutical formulation. Pharm Res. 2017;34:2270\u201386.","journal-title":"Pharm Res"},{"key":"3367_CR16","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1002\/jps.24039","volume":"103","author":"BM Teska","year":"2014","unstructured":"Teska BM, Alarc\u00f3n J, Pettis RJ, Randolph TW, Carpenter JF. Effects of phenol and meta-cresol depletion on insulin analog stability at physiological temperature. J Pharm Sci. 2014;103:2255\u201367.","journal-title":"J Pharm Sci"},{"key":"3367_CR17","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/j.1463-1326.2012.01580.x","volume":"14","author":"PD Home","year":"2012","unstructured":"Home PD. The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences. Diabetes Obes Metab. 2012;14:780\u20138.","journal-title":"Diabetes Obes Metab"},{"key":"3367_CR18","first-page":"1900094","volume":"75","author":"CL Maikawa","year":"2019","unstructured":"Maikawa CL, Smith AAA, Zou L, Meis CM, Mann JL, Webber MJ, Appel EA. Stable monomeric insulin formulations enabled by supramolecular PEGylation of insulin analogues. Adv Ther. 2019;75:1900094.","journal-title":"Adv Ther"},{"key":"3367_CR19","doi-asserted-by":"crossref","unstructured":"Mann JL, Maikawa CL, Smith AAA, Grosskopf AK, Baker SW, Roth GA, Meis CM, Gale EC, Liong CS, Correa S, Chan D, Stapleton LM, Yu AC, Muir B, Howard S, Postma A, Appel EA. An ultra-fast insulin formulation enabled by high throughput screening of polymeric excipients. Sci Transl Med. 2020;12:eaba6676.","DOI":"10.1126\/scitranslmed.aba6676"},{"key":"3367_CR20","volume-title":"Handbook of metal-ligand interactions in biological fluids","author":"G Berthon","year":"1995","unstructured":"Berthon G. Handbook of metal-ligand interactions in biological fluids. New York: Bioinorganic chemistry. Marcel Dekker; 1995."},{"key":"3367_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1385\/BTER:83:3:207","volume":"83","author":"RS Waters","year":"2001","unstructured":"Waters RS, Bryden NA, Patterson KY, Veillon C, Anderson RA. EDTA chelation effects on urinary losses of cadmium, calcium, chromium, cobalt, copper, lead, magnesium, and zinc. Biol Trace Elem Res. 2001;83:207\u201321.","journal-title":"Biol Trace Elem Res"},{"key":"3367_CR22","doi-asserted-by":"publisher","first-page":"2101575","DOI":"10.1002\/advs.202101575","volume":"8","author":"CL Maikawa","year":"2021","unstructured":"Maikawa CL, Chen PC, Vuong ET, Nguyen LT, Mann JL, d\u2019Aquino AI, Lal RA, Maahs DM, Buckingham BA, Appel EA. Ultra-fast insulin-pramlintide co-formulation for improved glucose management in diabetic rats. Adv Sci. 2021;8:2101575.","journal-title":"Adv Sci"},{"key":"3367_CR23","doi-asserted-by":"publisher","first-page":"14189","DOI":"10.1073\/pnas.1616639113","volume":"113","author":"MJ Webber","year":"2016","unstructured":"Webber MJ, Appel EA, Vinciguerra B, Cortinas AB, Thapa LS, Jhunjhunwala S, Isaacs L, Langer R, Anderson DG. Supramolecular PEGylation of biopharmaceuticals. Proc Natl Acad Sci U S A. 2016;113:14189\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3367_CR24","first-page":"15553","volume":"34","author":"JL Whittingham","year":"1995","unstructured":"Whittingham JL, Chaudhuri S, Dodson EJ, Moody PCE, Dodson GG. X-ray crystallographic studies on hexameric insulins in the presence of helix-stabilizing agents, thiocyanate. Methylparaben and Phenol Biochem. 1995;34:15553\u201363.","journal-title":"Methylparaben and Phenol Biochem"},{"key":"3367_CR25","doi-asserted-by":"publisher","first-page":"11516","DOI":"10.1021\/bi980807s","volume":"37","author":"JL Whittingham","year":"1998","unstructured":"Whittingham JL, Edwards DJ, Antson AA, Clarkson JM, Dodson GG. Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 Pro \u2192 Asp insulin analogues. Biochem. 1998;37:11516\u201323.","journal-title":"Biochem"},{"key":"3367_CR26","doi-asserted-by":"publisher","DOI":"10.1063\/1.5079501","volume":"150","author":"P Banerjee","year":"2019","unstructured":"Banerjee P, Mondal S, Bagchi B. Effect of ethanol on insulin dimer dissociation. J Chem Phys. 2019;150: 084902.","journal-title":"J Chem Phys"},{"key":"3367_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/protein\/5.6.527","volume":"5","author":"DN Brems","year":"1992","unstructured":"Brems DN, Alter LA, Beckage MJ, Chance RE, DiMarchi RD, Green LK, Long HB, Pekar AH, Shields JE, Frank BH. Altering the association properties of insulin by amino acid replacement. Protein Eng Des Sel. 1992;5:527\u201333.","journal-title":"Protein Eng Des Sel"},{"key":"3367_CR28","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1021\/acs.biomac.1c00474","volume":"22","author":"CL Maikawa","year":"2021","unstructured":"Maikawa CL, Mann JL, Kannan A, Meis CM, Grosskopf AK, Ou BS, Autzen AAA, Fuller GG, Maahs DM, Appel EA. Engineering insulin cold chain resilience to improve global access. Biomacromol. 2021;22:3386\u201395.","journal-title":"Biomacromol"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-022-03367-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-022-03367-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-022-03367-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T12:19:14Z","timestamp":1667477954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-022-03367-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["3367"],"URL":"https:\/\/doi.org\/10.1007\/s11095-022-03367-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.08.01.502380","asserted-by":"object"}]},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"assertion":[{"value":"16 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"E.A.A., J.L.M., and C.L.M. are listed as inventors on a provisional patent application (63\/011,928) filed by the Stanford University describing the technology reported in this manuscript. Also, E.A.A., L.T.N., and C.L.M. are listed as inventors on a provisional patent application (63\/389,708) filed by the Stanford University describing the technology reported in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of Interest"}},{"value":"All data supporting the results in this study are available within the Article and its Supplementary Information. Raw data files are available from the corresponding author upon reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}}]}}